Back to top

MacroGenics (MGNX) Receives a Buy from Barclays

In a report released today, Etzer Darout from Barclays maintained a Buy rating on MacroGenics, with a price target of $6.00. Darout covers the Heal...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

MacroGenics, Inc. (MGNX)